Tashkent, Uzbekistan (UzDaily.uz) — Uzbekistan and Hungarian pharmaceutical company EGIS have discussed expanding cooperation in the pharmaceutical sector, including investment and new projects in the Uzbek market.
Abdulla Azizov, director of Uzbekistan's Agency for the Development of the Medical and Pharmaceutical Industry, met representatives of EGIS on 18 November 2026, the agency said.
The talks focused on opportunities to expand pharmaceutical cooperation between Uzbekistan and Hungary.
The participants discussed prospects for developing EGIS's operations in Uzbekistan, attracting investment and implementing new projects.
They also exchanged views on medicine production, introducing modern technologies and expanding the range of pharmaceutical products. Particular attention was given to applying the company's international experience.
EGIS is among the pharmaceutical manufacturers in Central and Eastern Europe. Its products are available in 105 countries, and its portfolio includes 656 medicines.
In the 2024/2025 financial year, EGIS recorded sales of 773.3 million euros. The company allocated 56.6 million euros to research and development.